Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 11/27 03:59:06 pm
38.215 EUR   +1.45%
09:27aSwiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/26FRESENIUS SE : DZ Bank keeps its Buy rating
MD
11/24FRESENIUS SE : UBS remains Neutral
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
37.69(c) 38.03(c) 37.66(c) 37.67(c) 38.07 Last
1 169 715 1 390 401 1 225 697 756 156 1 041 907 Volume
-0.42% +0.90% -0.97% +0.03% +1.06% Change
More quotes
Financials
Sales 2020 36 301 M 43 418 M 43 418 M
Net income 2020 1 790 M 2 141 M 2 141 M
Net Debt 2020 24 198 M 28 943 M 28 943 M
P/E ratio 2020 12,0x
Yield 2020 2,10%
Sales 2021 38 061 M 45 524 M 45 524 M
Net income 2021 1 970 M 2 356 M 2 356 M
Net Debt 2021 21 482 M 25 694 M 25 694 M
P/E ratio 2021 10,6x
Yield 2021 2,28%
Capitalization 21 223 M 25 374 M 25 384 M
EV / Sales 2020 1,25x
EV / Sales 2021 1,12x
Nbr of Employees 309 114
Free-Float 72,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (49.2%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (31.4%;... 
More about the company
Notations Surperformance© of Fresenius SE & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS SE & CO. KGAA
09:27aSwiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/26FRESENIUS SE : DZ Bank keeps its Buy rating
MD
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
11/12FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
11/09Switzerland's Vifor strikes kidney drug deal with Angion
RE
11/06FRESENIUS SE : Kepler Cheuvreux gives a Buy rating
MD
11/05FMC FRESENIUS MEDICAL CARE AG & CO K : UBS maintains a Buy rating
MD
11/04FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
More news
News in other languages on FRESENIUS SE & CO. KGAA
07:45aINSIDER : Vifor Pharma hat Übernahme-Interessenten angelockt
02:23aMorning Briefing International
11/26Asklepios leidet unter Corona-Krise - deutlich weniger Patienten
11/26FRESENIUS SE : DZ Bank reste à l'achat
11/26DZ Bank senkt fairen Wert für Fresenius SE - 'Kaufen'
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 49,67 €
Last Close Price 38,07 €
Spread / Highest target 78,6%
Spread / Average Target 30,5%
Spread / Lowest Target -53,6%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-24.93%25 003
AIER EYE HOSPITAL GROUP CO., LTD.103.94%38 900
IHH HEALTHCARE2.38%12 084
BANGKOK DUSIT MEDICAL SERVICES0.00%11 805
RAMSAY HEALTH CARE LIMITED-12.06%10 689
TOPCHOICE MEDICAL CORPORATION101.14%10 057